Heiner Zimmermann

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

Ralf Ulrich Trappe, Stephan Oertel, Véronique Leblond et al. · The Lancet Oncology · 2011 · 386 citations

Medicine, Immunology, Oncology +9

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial

Ralf Ulrich Trappe, Daan Dierickx, Heiner Zimmermann et al. · Journal of Clinical Oncology · 2017 · 224 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases

Ralf Ulrich Trappe, Heiner Zimmermann, Susanne Fink et al. · Haematologica · 2011 · 60 citations · Full text

Medicine, Hematology, Pathology +17

EBV and posttransplantation lymphoproliferative disease: what to do?

Heiner Zimmermann, Ralf Ulrich Trappe · Hematology · 2013 · 43 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Plasmablastic Posttransplant Lymphoma

Heiner Zimmermann, Ilske Oschlies, Susanne Fink et al. · Transplantation · 2012 · 40 citations

Medicine, Hematology, Oncology +13